BIG PHARMAS, NOT SUCH AN ALL-WEATHER INVESTMENT
25/06/20 -"This story was first issued on 15-06-2020. ‘Valuation Wise’ takes a rest. Pre-COVID-19, holding Big Pharmas (seven issuers, €940bn market cap) would not make a big difference ..."
Pages
64
Language
English
Published on
25/06/20
You may also be interested by these reports :
05/11/26
Breaking down the European equity risk premium into two thematic components (Banks and France) offers a surprising analysis: banks matter more than ...
05/11/26
The group’s 3Q operating performance was weaker than expected. However, management maintained its financial objectives for 2026 and beyond. Last but ...
04/11/26
The group posted a good set of results leading management to upgrade its net interest income guidance, driven by stronger loan book growth. As ...
04/11/26
The group posted a good set of results, in line with its FY 2026 reaffirmed guidance, and solidifying management’s 2030 ambitions. As announced in ...